For Healthcare Entrepreneurs
Getting a new medical practice or healthcare business up and running sometimes means investing large sums of money, and when physician entrepreneurs don’t have the cash to make their visions reality, many turn to venture capitalists.
Here is a look at where these deals are being approved, and which industries are commanding the highest investments. Brought to you by focus.com in collaboration with Column Five
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
Filed under: Alerts Sign-Up, Practice Management, Research & Development | Tagged: healthcare entrepreneurs, medical innovation, VC, Venture Capital |
VC Investments In Health IT Jump 27%
While overall investments in healthcare declined, venture capitalists are increasing their bets on health IT.
http://money.msn.com/investment-advice/article.aspx?post=ddc84231-cdbe-488e-9e70-f2c283557318
Hope Rachel Hetico RN MHA
LikeLike
About Health Care Investment Visions ®
Health Care Investment Visions® is a venture management, funding and governance firm driven by deep industry knowledge and proven management principles.
Their focus is solely on corporate and individual entrepreneurship in the health care information technology sector. They advance innovation by managing context-determined risk using an adaptive management method, and govern by influencing resources along the course of action.
Check em’ out: http://www.hciv.com/about/index.html
Dr. David Edward Marcinko MBA
LikeLike
This M&A Boom Looks Different Than 2007
Corporate mergers and acquisitions are at the highest levels since 2007.
http://wealthmanagement.com/fixed-income/ma-boom-looks-different-2007?NL=WM-10&Issue=WM-10_20150613_WM-10_708&sfvc4enews=42&cl=article_3&utm_rid=CPG09000002702210&utm_campaign=2982&utm_medium=email&elq2=fbfb6a434f2443d5a618421d13daa420
Is this the top of the cycle?
Dr. David Edward Marcinko MBA CMP™
LikeLike
Is Health care Ripe for Disintermediation?
Ashton KutcherWhat do Ashton Kutcher, Donald Trump and Travis Kalanick have in common? They recognized an opportunity and used it to their advantage.
http://thehealthcareblog.com/blog/2016/01/19/is-health-care-ripe-for-disintermediation/
That trend: disintermediation—the opportunity to deliver a product or service to a consumer with higher perceived value than an incumbent’s by changing the fundamental way it is delivered.
Dr. David Marcinko MBA
http://www.BusinessofMedicalPractice.com
LikeLike
Venture capitalists are paying attention to NY
From the first annual New York City Healthcare Venture Capital Report 2018, lots of interesting data points:
1.There are approximately 300 venture firms investing in healthcare with headquarters or dedicated offices in New York City.
2.Overall the New York City VC industry remains fairly concentrated. With a hand in 25% of the deals in 2017, five firms that dominate are Orbimed, New Enterprise Associates, Venrock, Deerfield Management, and Canaan Partners.
3.The top 30 VCs are involved in almost 60% of the deal volume.
4.There are approximately 300 NYC-based healthcare companies that accounted for 510 deals between 2010 and 2017
5. In 2017, 79 healthcare companies received $703 million in funding.
Jay Dwivedi
LikeLike
PANDEMIC VENTURE CAPITAL and Physician Nurse Employment
https://www.propublica.org/article/coronavirus-er-doctors-nurses-benefits?utm_sq=gfnmz64nrn&utm_source=linkedin&utm_medium=social&utm_campaign=carlcschuesslerjrdhpdiagbds&utm_content=articles
Dr. David E. Marcinko MBA
LikeLike
Venture Capitalists in ERs
Today, an estimated 40-plus percent of the nation’s hospital emergency departments are overseen by for-profit health care staffing companies owned by private-equity firms, academic research, regulatory filings and internal documents show. Two of the largest, according to their websites and news releases, are Envision Healthcare, owned by KKR, and TeamHealth, of the Blackstone Group. EmCare, the health care staffing company that managed Brovont, is part of Envision.
Private-equity firms have taken over a broad swath of health care entities in recent years. They use large amounts of debt to acquire companies, aiming to increase their profits quickly so they can resell them at a gain in a few years.
Any thoughts?
Fredolin
LikeLike
2022 Year End
It may be the most wonderful time of the year but it’s also…Q4 layoff time. The latest: Goldman Sachs is planning to lay off as many as 4,000 employees, or roughly 8% of its workforce, Semafor reported yesterday.
Goldman Sachs also plans to trim or fully cut some employees’ year-end bonuses—which on Wall Street are a lot more than a $50 gift card to Macaroni Grill. Getting no bonus is called being “zeroed out” and is considered a strong nudge to quit.
Even so, Goldman Sachs’s workforce (currently 49,000) will remain bigger than it was before the pandemic (38,000). The bank hired aggressively in 2020 and 2021 while also suspending layoffs and buoying bonuses.
Stewart
LikeLike
UPDATE
Venture capitalists poured in nearly $22 billion in 2022, second only to the record $28 billion allocated in 2021, but that’ll likely dry up in 2023 as investments return to 2020 levels ($16.8 billion), according to a January report from SVB Financial Group, the parent of Silicon Valley Bank. (Not that we’re laughing at approximately $15 billion this year in anticipated VC fundraising for healthcare ventures—an area which has grown steadily over the last decade.)
The report highlighted some areas to watch:
Biopharma: Investment in the biopharma sector totaled $29.5 billion in 2022, down from $38.7 billion in 2021 despite a strong first quarter. It is expected to hover around 2020 levels ($27.4 billion in total) this year, but with increased funding in autoimmune and respiratory companies.
Medical devices: The sector kept pace last year with the 2021 record investments (a total of $8.5 billion compared to $9.2 billion, respectively). Investment in 2023 is expected to largely mirror what we saw in 2020 ($6.6 billion), but we can expect fewer $100+ million deals, given fundraising for top companies in 2022.
Medical diagnostics: Investment in medical diagnostics and tools companies is likely to rebound from the second half of 2022 and finish the year at $8 billion–$9 billion, just below the 2020 pace ($10.9 billion). Sector investment fell from a total of $14.7 billion in 2021 to $9.9 billion in 2022.
DEM
LikeLike